Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine
On May 18, 2020, Moderna, Inc. of Cambridge, Massachusetts announced that it had obtained “positive interim clinical data” from a Phase 1 human clinical trial of its experimental mRNA-1273 COVID-19 vaccine that began on Mar. 16. The biotechnology company said that eight of the 45 healthy adult volunteer trial subjects developed antibodies that may provide […]
U.S. Marines and Navy Prepare to Execute Pandemic Plan As Questions Resurface About Coronavirus Origin
Responding to the coronavirus outbreak in China, where tens of thousands of citizens suspected of being infected with coronavirus (COVID-2019) have been detained and involuntarily taken to quarantine camps,1 on Feb. 1, 2020 an executive order was issued by the U.S. Department of Defense (DoD), including the Joint Chiefs of Staff, directing the U.S. Northern […]